Neurodevelopmental Diagnostic Assessments

The NHS Wales Shared Services Partnership-Procurement Services, hosted by Velindre University NHS Trust, has confirmed the awarding of a contract to Healios Limited for Neurodevelopmental Diagnostic Assessments. This procurement process falls under the Health Services (Provider Selection Regime) (Wales) Regulations 2025, exempting it from the Public Contracts Regulations 2015/Procurement Act 2023. The service, classified under the CPV code 85121291 for paediatric services, primarily targets the Cardiff region (UKL22).

The contract was awarded following a direct award under a framework agreement without competition, due to the supplier's ability to quickly meet the outlined timeline requirements. The targeted completion date for initial contacts is set for 31st March 2026, with the contract being active for a period of 180 days, with signing confirmed on 7th January 2026. This tender poses significant growth prospects for businesses in the healthcare service sector that specialise in paediatric diagnostics and possess the capability to deliver timely and scalable solutions.

Companies like Healios Limited, which hold a successful track record in managing similar undertakings under tight deadlines, exemplify the ideal fit for such competitive bids. The procurement creates opportunities for businesses that can efficiently manage paediatric assessments, particularly those skilled in neurodevelopmental areas such as autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD). Engaging in this government initiative provides the potential for business expansion, securing additional work under governmental contracts, and strengthening relationships within public health sectors.